Dustin Sjuts
2021
In 2021, Dustin Sjuts earned a total compensation of $3.2M as President at Revance Therapeutics, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $200,908 |
|---|---|
| Option Awards | $634,014 |
| Salary | $434,805 |
| Stock Awards | $1,767,178 |
| Other | $193,506 |
| Total | $3,230,411 |
Sjuts received $1.8M in stock awards, accounting for 55% of the total pay in 2021.
Sjuts also received $200.9K in non-equity incentive plan, $634K in option awards, $434.8K in salary and $193.5K in other compensation.
Rankings
In 2021, Dustin Sjuts' compensation ranked 4,141st out of 12,405 executives tracked by ExecPay. In other words, Sjuts earned more than 66.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,141 out of 12,405 | 67th |
Division Manufacturing | 1,705 out of 5,494 | 69th |
Major group Chemicals And Allied Products | 704 out of 2,369 | 70th |
Industry group Drugs | 626 out of 2,090 | 70th |
Industry Pharmaceutical Preparations | 440 out of 1,537 | 71st |
Pay ratio
| Dustin Sjuts' Pay | $3,230,411 |
|---|---|
| Median Employee's Pay | $248,326 |
| Pay Ratio | 13to 1 |
In 2021, the annual total compensation of Dustin Sjuts was $3,230,411.
The annual total compensation of the median employee at Revance Therapeutics was $248,326.
The ratio of Dustin Sjuts' pay to the pay of median employee was therefore 13 to one.
Source: SEC filing on March 24, 2022.
Sjuts' colleagues
We found four more compensation records of executives who worked with Dustin Sjuts at Revance Therapeutics in 2021.